Joseph P. Davide

3.9k total citations · 1 hit paper
37 papers, 2.1k citations indexed

About

Joseph P. Davide is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Joseph P. Davide has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Joseph P. Davide's work include Protein Kinase Regulation and GTPase Signaling (6 papers), RNA and protein synthesis mechanisms (5 papers) and Click Chemistry and Applications (4 papers). Joseph P. Davide is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (6 papers), RNA and protein synthesis mechanisms (5 papers) and Click Chemistry and Applications (4 papers). Joseph P. Davide collaborates with scholars based in United States, China and Israel. Joseph P. Davide's co-authors include George C. Prendergast, Peter F. Lebowitz, John A. Lewis, Laura Sepp‐Lorenzino, Nancy E. Kohl, Peter W. Melera, Weikang Tao, Robert B. Lobell, Julie A. Waterbury and Victoria J. South and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Joseph P. Davide

37 papers receiving 2.0k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant

1990 579 citations Gregory J. LaRosa, Joseph P. Davide et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph P. Davide United States	22	1.3k	508	461	392	287	37	2.1k
T. Jesse Kwoh United States	22	1.3k 1.0×	660 1.3×	294 0.6×	404 1.0×	78 0.3×	41	2.4k
Bernard Krust France	31	1.7k 1.3×	1.2k 2.4×	467 1.0×	555 1.4×	214 0.7×	66	3.3k
J J Toole United States	16	1.2k 0.9×	200 0.4×	258 0.6×	310 0.8×	73 0.3×	20	2.5k
Loı̈c Martin France	23	660 0.5×	738 1.5×	243 0.5×	352 0.9×	125 0.4×	56	1.6k
Erik S. Zimmerman United States	13	985 0.8×	502 1.0×	368 0.8×	238 0.6×	87 0.3×	14	1.5k
E P Gelmann United States	12	685 0.5×	539 1.1×	308 0.7×	352 0.9×	140 0.5×	18	2.0k
Gregory Roderiquez United States	20	509 0.4×	823 1.6×	563 1.2×	346 0.9×	104 0.4×	25	1.9k
Douglas F. Lake United States	25	614 0.5×	308 0.6×	152 0.3×	323 0.8×	115 0.4×	90	1.6k
Petra Neddermann Italy	27	1.8k 1.4×	188 0.4×	483 1.0×	223 0.6×	151 0.5×	36	3.2k
Georg Sczakiel Germany	30	2.8k 2.2×	269 0.5×	345 0.7×	298 0.8×	161 0.6×	96	3.4k

Countries citing papers authored by Joseph P. Davide

Since Specialization

Citations

This map shows the geographic impact of Joseph P. Davide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph P. Davide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph P. Davide more than expected).

Fields of papers citing papers by Joseph P. Davide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph P. Davide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph P. Davide. The network helps show where Joseph P. Davide may publish in the future.

Co-authorship network of co-authors of Joseph P. Davide

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph P. Davide. A scholar is included among the top collaborators of Joseph P. Davide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph P. Davide. Joseph P. Davide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davide, Joseph P., et al.. (2022). Development of process analytical tools for rapid monitoring of live virus vaccines in manufacturing. Scientific Reports. 12(1). 15494–15494. 9 indexed citations

Ha, Sha, Joseph P. Davide, Joseph P. Califano, et al.. (2021). Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO. Scientific Reports. 11(1). 7432–7432. 11 indexed citations

Ng, Bruce, Yi Wang, Jessica Seitzer, et al.. (2019). Intratracheal Administration of siRNA Triggers mRNA Silencing in the Lung to Modulate T Cell Immune Response and Lung Inflammation. Molecular Therapy — Nucleic Acids. 16. 194–205. 17 indexed citations

Tao, Weikang, Xianzhi Mao, Joseph P. Davide, et al.. (2010). Mechanistically Probing Lipid-siRNA Nanoparticle-associated Toxicities Identifies Jak Inhibitors Effective in Mitigating Multifaceted Toxic Responses. Molecular Therapy. 19(3). 567–575. 57 indexed citations

Abrams, Marc, Martin L. Koser, Jessica Seitzer, et al.. (2009). Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment. Molecular Therapy. 18(1). 171–180. 165 indexed citations

Roecker, Anthony J., Paul J. Coleman, Swati P. Mercer, et al.. (2007). Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP. Bioorganic & Medicinal Chemistry Letters. 17(20). 5677–5682. 35 indexed citations

Dinsmore, Christopher J., C. Blair Zartman, Jeffrey M. Bergman, et al.. (2004). Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 14(3). 639–643. 8 indexed citations

Lobell, Robert B., Joseph P. Davide, Nancy E. Kohl, et al.. (2003). A Cell-Based Radioligand Binding Assay for Farnesyl: Protein Transferase Inhibitors. SLAS DISCOVERY. 8(4). 430–438. 1 indexed citations

Tucker, Thomas J., Marc Abrams, Carolyn A. Buser, et al.. (2002). The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases. Bioorganic & Medicinal Chemistry Letters. 12(15). 2027–2030. 13 indexed citations

10.

Bergman, Jeffrey M., Marc Abrams, Joseph P. Davide, et al.. (2001). Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 11(11). 1411–1415. 25 indexed citations

11.

Bergman, Jeffrey M., Donna Wei, C. Blair Zartman, et al.. (2001). Oxo-piperazine Derivatives of N-Arylpiperazinones as Inhibitors of Farnesyltransferase. Bioorganic & Medicinal Chemistry Letters. 11(4). 537–540. 22 indexed citations

12.

Lemon, Stanley M., Paula C. Murphy, P. J. Provost, et al.. (1997). Immunoprecipitation and Virus Neutralization Assays Demonstrate Qualitative Differences between Protective Antibody Responses to Inactivated Hepatitis A Vaccine and Passive Immunization with Immune Globulin. The Journal of Infectious Diseases. 176(1). 9–19. 32 indexed citations

13.

Prendergast, George C., Joseph P. Davide, Peter F. Lebowitz, Robert J. Wechsler‐Reya, & Nancy E. Kohl. (1996). Resistance of a variant ras-transformed cell line to phenotypic reversion by farnesyl transferase inhibitors.. PubMed. 56(11). 2626–32. 39 indexed citations

14.

Lebowitz, Peter F., Joseph P. Davide, & George C. Prendergast. (1995). Evidence that Farnesyltransferase Inhibitors Suppress Ras Transformation by Interfering with Rho Activity. Molecular and Cellular Biology. 15(12). 6613–6622. 181 indexed citations

15.

Ellerbeck, Edward F., John A. Lewis, David R. Nalin, et al.. (1992). Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A. Vaccine. 10(10). 668–672. 22 indexed citations

16.

Scotto, Kathleen W., et al.. (1992). Differential utilization of poly (A) signals between DHFR alleles in CHL cells. Nucleic Acids Research. 20(24). 6597–6604. 6 indexed citations

17.

Devine, Scott E., Arif Hussain, Joseph P. Davide, & Peter W. Melera. (1991). Full length and alternatively spliced pgp1 transcripts in multidrug-resistant Chinese hamster lung cells. Journal of Biological Chemistry. 266(7). 4545–4555. 38 indexed citations

18.

LaRosa, Gregory J., Joseph P. Davide, Kent J. Weinhold, et al.. (1990). Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant. Science. 249(4971). 932–935. 579 indexed citations breakdown →

19.

Melera, Peter W., Joseph P. Davide, Catherine Hession, & Kathleen W. Scotto. (1984). Phenotypic Expression in Escherichia coli and Nucleotide Sequence of Two Chinese Hamster Lung Cell cDNAs Encoding Different Dihydrofolate Reductases. Molecular and Cellular Biology. 4(1). 38–48. 10 indexed citations

20.

Roberts, Michael L., Peter W. Melera, Joseph P. Davide, John Hart, & F.H. Ruddle. (1983). Assignment of the native Chinese hamster dihydrofolate reductase gene to chromosome 2. Cytogenetic and Genome Research. 36(4). 599–604. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact